Skip to main content

Elevated levels of neutrophils with a pro-inflammatory profile in Turner syndrome across karyotypes.

NPJ genomic medicine2025-02-07PubMed
Total: 77.5Innovation: 9Impact: 7Rigor: 7Citation: 8

Summary

Using methylome and transcriptome profiling across karyotypes, the study shows a shared autosomal signature in Turner syndrome driven by loss of Xp (including PAR1), independent of XIST. Neutrophils are increased and activated, linked to TBL1X expression and clinical traits, suggesting neutrophil-driven inflammatory stress as a mechanistic contributor to TS comorbidities.

Key Findings

  • Common autosomal methylome and transcriptome across TS despite different karyotypes
  • Universal loss of Xp (including PAR1); XIST expression from Xq did not alter autosomal omics
  • Elevated neutrophil levels and activation linked to TS clinical traits
  • Neutrophil increase associated with higher expression of X–Y homolog TBL1X, suggesting a genetic basis

Clinical Implications

Consider monitoring neutrophil counts/activation and inflammatory markers in Turner syndrome as part of cardiometabolic risk assessment. Findings may inform future trials targeting innate immune pathways to mitigate metabolic and autoimmune comorbidities.

Why It Matters

Reveals a novel immune–genetic mechanism in Turner syndrome linking Xp loss and TBL1X to neutrophil activation, reframing comorbidity risk beyond gonadal failure alone. Provides testable biomarkers for risk stratification.

Limitations

  • Sample size and cohort details not specified in the abstract
  • Cross-sectional design limits causal inference and clinical outcome linkage
  • External validation in independent cohorts is needed

Future Directions

Validate neutrophil activation and TBL1X as biomarkers in independent TS cohorts; longitudinal studies to link inflammatory signatures with cardiometabolic outcomes; explore targeted anti-inflammatory or immunomodulatory interventions.

Study Information

Study Type
Case-control study
Research Domain
Pathophysiology
Evidence Level
III - Translational, cross-sectional comparison with multi-omics; hypothesis-generating mechanistic evidence
Study Design
OTHER